Is Xometry Stock Still a Buy After a 144% Six-Month Run?
Xometry (XMTR) stock has surged 144% in six months, driven by strong Q2 earnings and a Siemens partnership. Q2 revenue was $229.28M, up 41% YoY, beating estimates. Analysts have raised targets to $110, 14% above current price. Insiders have sold $3.46M in stock since July.
How this was made

The 30-second read
Why it matters
The earnings beat and upgraded guidance justify a higher price target, but insider sales introduce a cautionary note.
Market read
The earnings surprise and guidance lift Xometry's valuation outlook, influencing mid‑cap growth and AI‑enabled manufacturing stocks.
What to watch
Potential execution risk of the Siemens integration and macro‑economic headwinds for capital equipment spending.
Background
Xometry reported Q2 2026 results, beating revenue estimates and raising its full‑year guidance, while insiders sold $3.5 M of stock.
Ticker impact
Q2 2026 earnings beat expectations and raised full-year revenue guidance, driving a 144% six‑month price run.
Potential upside toward the $110 mean target if guidance holds, with downside risk from insider sales.
Revenue beat and guidance raise expectations, but insider selling and delayed partnership benefits add uncertainty.
Market effects
Positive for custom manufacturing and AI‑driven pricing platforms, may lift peers in the on‑demand manufacturing space.
U.S. tech and industrial sectors see modest uplift.
Limited to investors tracking AI‑enabled manufacturing and mid‑cap growth stocks.
Counterpoint
Insider selling and the partnership revenue not materializing until 2027 could cap upside.
Key entities
- CompanyXometry, Inc.
Custom manufacturing marketplace reporting Q2 earnings.
- PartnerSiemens AG
Provided a $50 M equity investment and integration partnership.


